Monsanto India Limited
FIRST QUARTER RESULTS
Q1 FY 2013
MONSANTO INDIA LIMITED has released its results for the Q/E June
2012. The High Lights of the results are as below :
Net Sales stands at Rs.199.80
Cr for Q1 FY 13; compared to Rs.35.13 cr in Q4 FY 12 (Up 468.74%) ; and Rs.185.49
Cr in Q1 FY 12 (Up 7.71%).
Total Expenditure stands at Rs.154.19
Cr for Q1 FY 13; compared to Rs.44.48 Cr in Q4 FY 12 (Up 246.65%); and Rs.141.05
Cr in Q1 FY 12 (UP 9.32%)
Net Profit stands
at Rs.48.63 Cr in Q1 FY 13 ;compared to Rs.(-)7.63 Cr in Q4 FY 12 (Down -737.35%);
and Rs.44.06 Cr in Q1 FY 12 (Up 10.37%).
Diluted EPS stands at Rs.28.17
in Q1 FY 13; Rs.(-)4.42 in Q4 FY 12; and Rs.51.04 in Q1 FY 12. The Q1 FY 12 EPS is
on lower Equity of Rs.8.63 Cr, while the others are on enhanced Equity of
Rs.17.26 Cr – due to a 1:1 Bonus issue last year. The March ending Quarter
appears to be a Lean quarter for the company. The Q4 FY 11 also had an EPS of
Rs(-)13.06.
52 week high/low price : 1943.00/555.55
Current MP : Rs.632. The annualized
EPS and PE Ratio are not computed as each quarter has difference sales and
Profits levels for this Agri Products company.
About the Company :-
Monsanto India Limited (MIL) - a subsidiary of
the Monsanto Company, USA - is the only publicly listed Monsanto entity outside
USA.
With a presence of
more than six decades in India, MIL is committed to help the Indian farmer
produce more while conserving sustainably and to be successful. MIL focuses on
maize (Dekalb®, India's largest selling hybrid maize seed brand) and
agricultural productivity (Roundup®, the world, as well as India's largest
selling glyphosate herbicide).
MIL endeavors to
boost crop productivity through its advanced research in maize cultivation,
access to a wide library of global maize germplasm, breeding technology and
techniques, new high-yielding hybrid seeds, best-in-class manufacturing
facilities, extensive agronomic activities and on-farm technology development.
TABLE
OF RESULTS
MONSANTO
|
30-Jun-12
|
31-Mar-12
|
QoQ
DIF%
|
30-Jun-11
|
YoY DIF %
|
Net Sales
|
19980
|
3513
|
468.74
|
18549
|
7.71
|
Total Expenditure
|
15419
|
4448
|
246.65
|
14105
|
9.32
|
Profit
before Interest, Dep. & Taxes
|
4561
|
-935
|
-587.81
|
4444
|
2.63
|
Net Profit
|
4863
|
-763
|
-737.35
|
4406
|
10.37
|
Diluted EPS
|
28.17
|
-4.42
|
-737.33
|
51.04
|
-44.81
|
Net Sales
|
19980
|
3513
|
468.74
|
18549
|
7.71
|
Changes in inventories of finished goods, WIP
and SIT
|
6418
|
-5228
|
-222.76
|
5256
|
22.11
|
Cost of materials
|
4405
|
6367
|
-30.82
|
4308
|
2.25
|
Employee benefits
|
1064
|
1080
|
-1.48
|
944
|
12.71
|
Depreciation
|
236
|
240
|
-1.67
|
226
|
4.42
|
Other expenses
|
3296
|
1955
|
68.59
|
3371
|
-2.22
|
Total expenses
|
15419
|
4448
|
246.65
|
14105
|
9.32
|
Profit
before tax
|
5387
|
-392
|
-1474.23
|
4970
|
8.39
|
Tax Expenses
|
524
|
371
|
41.24
|
564
|
-7.09
|
Net Profit
|
4863
|
-763
|
-737.35
|
4406
|
10.37
|
Face Value of Share (inRs )
|
10
|
10
|
0
|
10
|
0
|
Paid-up Equity
|
1726
|
1726.24
|
-0.01
|
863
|
100
|
Diluted EPS
|
28.17
|
-4.42
|
-737.33
|
51.04
|
-44.81
|
Public Shareholding (%)
|
27.85
|
27.85
|
0
|
27.85
|
0
|
* *
* E N D *
* *
No comments:
Post a Comment